DIGOXIN

LOE Approaching

digoxin

NDAORALELIXIR
Approved
Aug 2004
Lifecycle
LOE Approaching
Competitive Pressure
60/100
Clinical Trials
20

Mechanism of Action

digoxin's actions are mediated through its effects on NaK–ATPase. This enzyme, the "sodium pump," is responsible for maintaining the intracellular milieu throughout the body by moving sodium ions out of and potassium ions into cells. By inhibiting NaK–ATPase, digoxin • causes increased availability…

Pharmacologic Class:

Cardiac Glycoside

Clinical Trials (5)

NCT07215260Phase 1Completed

A Study in Healthy People to Test Whether BI 3000202 Affects How 2 Other Medicines (Rosuvastatin and Digoxin) Are Taken up in the Body

Started Nov 2025
14 enrolled
Healthy
NCT06921941Phase 1Completed

Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Digoxin and Rosuvastatin

Started Apr 2025
NCT06597760Phase 1Completed

A Clinical Study to Assess the Effect of Enlicitide on How the Body Processes Digoxin in Healthy Adult Participants (MK-0616-031)

Started Oct 2024
24 enrolled
Healthy
NCT06575933Phase 1Completed

A Study of Calderasib (MK-1084) With Midazolam and Digoxin in Healthy Participants (MK-1084-009)

Started Sep 2024
28 enrolled
Non-small Cell Lung Cancer
NCT06503679Phase 1Completed

A Drug-drug Interaction Study Evaluating the Perpetrator Potential of LY4100511 (DC-853) on Midazolam, Repaglinide, Digoxin, Rosuvastatin in Healthy Participants

Started Jul 2024
49 enrolled
Healthy